---
title:  "MANAGEMENT / OUTCOMES"
layout: page
permalink: /MANAGEMENT _ OUTCOMES/
nav_order: 4
---

1. Antimicrobials  
   1. Be familiar with 1\) dosing 2\) treatment course 3\) common side effects of the first-line antimicrobial regimens used to treat the following common neuroinfectious conditions:  
      1. Bacterial meningitis:  
         1. Vancomycin  
         2.  3rd generation cephalosporins, cefepime  
         3. Ampicillin  
      2. Herpesviruses (HSV, VZV, CMV, HHV-6):  
         1.  Acyclovir  
         2. Valacyclovir  
         3. Ganciclovir  
         4. Valganciclovir  
         5. Foscarnet  
      3. Fungal infections:  
         1.  Amphotericin  
         2. Flucytosine  
         3. Azoles specifically fluconazole and voriconazole  
      4. Parasites specifically toxoplasmosis:  
         1. Sulfadiazine  
         2. Pyrimethamine  
         3. Leucovorin  
      5. Mycobacterium specifically tuberculosis:  
         1. Rifampin  
         2. Isoniazid  
         3. Pyrimethamine  
         4. Ethambutol  
      6. Nocardia:  
         1.  TMP-SMX  
         2. Linezolid  
      7. Syphilis:  
         1. Penicillin G  
      8. Rickettsial bacteria:  
         1. Ceftriaxone  
         2. Doxycycline  
      9. Be familiar with experimental treatments for infections including PML (pembrolizumab) and HTLV-1 (mogamulizumab)  
      10. Botulism:  
          1. Antitoxin  
      11. Tetanus:  
          1. Metronidazole  
   2. HIV \+ ART  
      1. Be familiar with the four major categories of ART type  
         1. NRTI (nucleoside reverse transcriptase inhibitor)  
         2. NNRTI (non-nucleoside reverse transcriptase inhibitor)  
         3.  INSTI (integrase strand inhibitor)  
         4. PI (protease inhibitor)  
      2. Be familiar with the most common first line ART combination used to treat HIV:  
         1. Two NRTIs \+ one medication from the three other classes listed above  
      3. Be aware that long-acting injectable ART is now available  
      4. Understand ART that is associated with cognitive impairment  
         1. Efavirenz  
      5. Understand ART most commonly associated with neuropathy  
         1.  NRTIs: Didanosine, Zalcitabine, Stavudine  
      6. Understand ART most commonly associated with cardiovascular disease including stroke  
         1. Abacavir  
         2. Protease inhibitors  
      7. Review that CNS penetration efficiency (CPE) score of ART is no longer used to determine empiric ART regimen, but that CSF HIV genotyping may be used to adjust ART regimens in settings of symptomatic HIV CNS RNA escape   
      8. Understand when to consider delaying ART initiation in the setting of new HIV and CNS opportunistic infections  
         1. CNS cryptococcus  
         2. CNS tuberculosis  
2. Immunomodulatory treatment  
   1. Understand necessary infectious pre-screening testing prior to beginning immune modulatory therapy   
      1. HBV/HCV testing  
      2. HIV screening   
      3. Tuberculosis screening  
      4. Strongyloides antibody testing (or empiric treatment) if from endemic region   
   2. Understand the indication for corticosteroids used to treat the following conditions:  
      1. Bacterial meningitis  
      2. Immune reconstitution syndrome (IRIS)  
      3. Neurocysticercosis  
      4. Tuberculous meningitis  
      5. Viral meningitis (Varicella zoster, Epstein-Barr encephalitis)  
   3. Understand the limitations or contraindications for corticosteroids used to treat the following conditions:  
      1. Certain bacterial meningitis (ex: Listeria)  
      2. Viral meningitis (ex: Herpesvirus)  
   4. Understand the limitations for IVIG used to treat the following conditions:  
      1. Viral encephalitis  
   5. Be familiar with emerging investigational therapy used to treat PML  
      1. Immune checkpoint inhibitors  
      2. Virus specific T-cells  
      3. Interleukins  
   6. Be familiar with the immune suppressing medications used for refractory IRIS  
      1. Anti-TNF (e.g. infliximab)  
      2. Maraviroc  
3. Surgical treatment  
   1. Understand the complications from acute neuroinfectious diseases that may require neurosurgical intervention  
      1. Abscess drainage  
      2. CSF Shunting  
      3. ICP Monitoring / Craniectomy  
         1. Cerebral edema  
         2. Hydrocephalus   
         3. Intracranial hypertension  
   2. Understand the indication for CSF shunting for chronic neuroinfectious diseases  
      1. Cryptococcal meningitis  
4. Common complications / long-term sequelae  
   1. Understand long-term sequelae patients with neuroinfectious diseases may encounter after the acute phase  
      1. Meningoencephalitis  
         1.  Cognitive syndrome  
            1. Learning difficulties  
            2. Memory problems  
            3. Speech problems  
         2. Dysphagia  
         3.  Fatigue  
         4. Headache and pain syndromes  
         5. Hearing loss  
         6. Neurobehavioral dysregulation  
         7.  Parkinsonism and gait disorder  
         8. Seizures  
         9. Vestibular syndrome  
         10. Vision loss  
      2. Myelitis  
         1. Bowel and / or bladder incontinence  
         2. Chronic pain syndrome and spasticity  
         3. Motor weakness and gait disorder  
         4. Recurrent infections from immobility  
         5. Sexual dysfunction  
      3. Peripheral nervous system infections  
         1. Chronic pain syndromes  
         2. Motor weakness and gait disorder  
   2. Understand the utility for longitudinal surveillance for laboratory markers for specific pathogens in patients with stable and active / recurrent symptoms  
      1. Repeat culture in the blood and CSF  
      2. Repeat PCR in the blood and CSF  
      3. Repeat Serology in the blood and CSF

